Intrahepatic chemotherapy for unresectable cholangiocarcinoma: review of literature and personal experience
Marco Massani(AULSS 2 Marca Trevigiana), Nicolò Bassi(University of Padua), Cesare Ruffolo(Ca' Foncello Hospital), Bruno Pauletti(AULSS 2 Marca Trevigiana), Luca Fabris(University of Padua), Luca Bonariol(Ca' Foncello Hospital), R. Bonariol(Ca' Foncello Hospital), Cristina Nistri(AULSS 2 Marca Trevigiana), Giovanni Morana(Ca' Foncello Hospital), Ezio Caratozzolo(AULSS 2 Marca Trevigiana)
Cited by 32
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
|Journal of Crohn s and Colitis|2013|669
The tumour microenvironment and immune milieu of cholangiocarcinoma
|Liver International|2019|194
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
|Journal of Hepatology|2018|191